These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1145932)

  • 1. Advanced prostatic carcinoma: flutamide therapy after conventional endocrine treatment.
    Sogani PC; Ray B; Whitmore WF
    Urology; 1975 Aug; 6(2):164-6. PubMed ID: 1145932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with flutamide in previously untreated patients with advanced prostatic cancer.
    Sogani PC; Whitmore WF
    J Urol; 1979 Nov; 122(5):640-3. PubMed ID: 501817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flutamide therapy for advanced prostatic cancer: a phase II study.
    MacFarlane JR; Tolley DA
    Br J Urol; 1985 Apr; 57(2):172-4. PubMed ID: 3986452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy.
    Sogani PC; Vagaiwala MR; Whitmore WF
    Cancer; 1984 Aug; 54(4):744-50. PubMed ID: 6378356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
    St Arnaud R; Lachance R; Dupont A; Labrie F
    J Clin Endocrinol Metab; 1986 Aug; 63(2):297-302. PubMed ID: 3522618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of combination therapy with flutamide in patients relapsing after castration.
    Labrie F; Dupont A; Giguere M; Borsanyi JP; Lacourciere Y; Monfette G; Emond J; Bergeron N
    Br J Urol; 1988 Apr; 61(4):341-6. PubMed ID: 3289676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
    Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
    Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
    J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma.
    Sogani PC; Whitmore WF
    Cancer Treat Res; 1988; 39():131-45. PubMed ID: 2908604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flutamide in the treatment of advanced carcinoma of the prostate].
    Vomácka V; Vachalovský V
    Rozhl Chir; 1985 Nov; 64(11):723-8. PubMed ID: 4089703
    [No Abstract]   [Full Text] [Related]  

  • 11. Flutamide--an antiandrogen inhibiting prostatic cancer and prostatic secretion with retention of potency.
    Stegmayr B; Johansson JE; Schnürer LB
    Med Oncol Tumor Pharmacother; 1988; 5(1):61-5. PubMed ID: 3367673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer.
    Labrie F; Dupont A; Cusan L; Manhès G; Bergeron N; Lacourcière Y; Pineault S; Bélanger A; Monfette G; Emond J
    Prog Clin Biol Res; 1989; 303():161-7. PubMed ID: 2674982
    [No Abstract]   [Full Text] [Related]  

  • 13. A pilot study of flutamide. A new agent in the treatment of advanced prostatic cancer.
    Sarfaty GA; Alder SJ; McLean RG
    Med J Aust; 1984 Feb; 140(4):219-21. PubMed ID: 6694625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of flutamide and estramustine as initial treatment of metastatic carcinoma of prostate.
    Johansson JE; Andersson SO; Beckman KW; Lingårdh G; Zador G
    Urology; 1987 Jan; 29(1):55-9. PubMed ID: 3798631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adrenalectomy, flutamide, and leuprolide on the growth of the Dunning rat R-3327 prostatic carcinoma.
    Kung TT; Mingo GG; Siegel MI; Watnick AS
    Prostate; 1988; 12(4):357-63. PubMed ID: 3134647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study.
    Lund F; Rasmussen F
    Br J Urol; 1988 Feb; 61(2):140-2. PubMed ID: 3280080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bicalutamide: a new antiandrogen for use in combination with castration for patients with advanced prostate cancer.
    Blackledge G; Kolvenbag G; Nash A
    Anticancer Drugs; 1996 Jan; 7(1):27-34. PubMed ID: 8742095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flutamide as primary treatment for metastatic prostatic cancer.
    Lundgren R
    Br J Urol; 1987 Feb; 59(2):156-8. PubMed ID: 3828712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alternative antiandrogen therapy with flutamide in patients with castration-resistant prostate cancer : a single center experience].
    Takada T; Ishizuya Y; Okada T; Ueda T; Inoue H; Hara T
    Hinyokika Kiyo; 2011 Jun; 57(6):291-5. PubMed ID: 21795830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced prostatic cancer with flutamide.
    Sanford EJ; Bowditch RR; Rohner TJ; Bardin CW
    Pa Med; 1979 Sep; 82(9):29-31. PubMed ID: 386212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.